Prescription drug · NDA
Clindagel (Clindamycin) NDC 16781-462
Clindamycin phosphate 10 mg/mL · Gel · Topical · Bausch Health US, LLC
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 16781-462-06 | 1678104620616781046206 | 6 BOTTLE in 1 CARTON (16781-462-06) / 7.3 mL in 1 BOTTLEMarketed from Jul 1, 2015 · Sample package | |
| 16781-462-75 | 1678104627516781046275 | 1 BOTTLE in 1 CARTON (16781-462-75) / 75 mL in 1 BOTTLEMarketed from Nov 25, 2013 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Clindagel
- Generic name (nonproprietary)
- clindamycin
- Active ingredients
- Clindamycin phosphate — 10 mg/mL
- Dosage form
- Gel
- Route
- Topical
- Labeler
- Bausch Health US, LLCNDC labeler code 16781
- Product type
- Prescription drug
- Marketing category
- NDA — New Drug ApplicationApplication NDA 050782
- Marketing start
- Listing expires
- Other FDA classes
- Decreased Sebaceous Gland Activity (Physiologic effect)Lincosamides (Chemical structure)Neuromuscular Blockade (Physiologic effect)
- Identifiers
- Product ID 16781-462_cb49818a-19bc-4bcc-8696-a8b749fefbe4SPL ID cb49818a-19bc-4bcc-8696-a8b749fefbe4SPL set ID f7b4e985-719a-4547-b624-94612d520991RxCUI 309332, 351330UNII EH6D7113I8
- Pharmacologic class
- Lincosamide Antibacterial
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Topical products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N416781046206followed by a unit qualifier and the quantityPackage 16781-0462-06. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
CLINICAL STUDIES In one 12-week multicenter, randomized, evaluator-blind, vehicle-controlled, parallel comparison clinical trial in which patients used CLINDAGEL (clindamycin phosphate topical gel, 1%) once daily or the vehicle gel once daily, in the treatment of acne vulgaris of mild to moderate severity, CLINDAGEL applied once daily was more effective than the vehicle applied once daily. The mean percent reductions in lesion counts at the end of treatment in this study are shown in the following table: Lesions CLINDAGEL QD N=162 Vehicle Gel QD N=82 Inflammatory 51% 40% P<0.05 Noninflammatory 25% 12% Total 38% 27% There was a trend in the investigator’s global assessment of the results, whi…
Excerpt only. Read the full label for complete information.
About NDC 16781-462
- What is NDC 16781-462?
- 16781-462 is the product NDC for Clindagel (clindamycin), Clindamycin phosphate 10 mg/mL gel, listed with the FDA by Bausch Health US, LLC. It has 2 package NDCs, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Clindagel (Clindamycin).
- What is the active ingredient?
- Clindamycin phosphate.
- Who is the labeler?
- Bausch Health US, LLC, NDC labeler code 16781. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Clindagel?
- None: this is the only finished product listed under this name.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Other NDCs under NDA 050782
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Clindamycin Phosphate | Clindamycin phosphate 10 mg/mL | GelTopical | Oceanside Pharmaceuticals | 68682-462 |